Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
UQCRHP1 (Ubiquinol-cytochrome c reductase hinge protein pseudogene 1) is annotated as a pseudogene in the human genome, located at cytogenetic position 6:31611083-31611356[6]. It does not produce a functional protein, nor is it recognized as a therapeutic target. The genuine protein-coding gene in this family is UQCRH (ubiquinol-cytochrome c reductase hinge protein), which encodes a subunit of Complex III in the mitochondrial electron transport chain. UQCRHP1 is sometimes confused with its protein-coding paralogues (e.g., UQCRH, UQCRFS1), but it does not serve biological functions nor play a role in disease as a protein product[4][8]. There is no evidence that drugs interact with UQCRHP1, or that it serves as a biomarker or is associated with safety concerns.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ubiquinol-cytochrome c reductase hinge protein pseudogene 1 (UQCRHP1).